NasdaqGM - Nasdaq Real Time Price USD

AtriCure, Inc. (ATRC)

Compare
31.67 -1.12 (-3.42%)
At close: December 13 at 4:00:02 PM EST
31.67 0.00 (0.00%)
After hours: December 13 at 5:19:04 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
447,573.00
399,245.00
330,379.00
274,329.00
206,531.00
Cost of Revenue
112,853.00
98,875.00
84,439.00
68,469.00
57,222.00
Gross Profit
334,720.00
300,370.00
245,940.00
205,860.00
149,309.00
Operating Expense
368,878.00
327,053.00
288,609.00
253,155.00
193,899.00
Operating Income
-34,158.00
-26,683.00
-42,669.00
-47,295.00
-44,590.00
Net Non Operating Interest Income Expense
-2,483.00
-3,133.00
-2,992.00
-4,452.00
-3,784.00
Other Income Expense
-1,147.00
-31.00
-537.00
102,134.00
333.00
Pretax Income
-37,788.00
-29,847.00
-46,198.00
50,387.00
-48,041.00
Tax Provision
1,131.00
591.00
268.00
188.00
114.00
Net Income Common Stockholders
-38,919.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Diluted NI Available to Com Stockholders
-38,919.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Basic EPS
-0.83
-0.66
-1.02
1.11
-1.14
Diluted EPS
-0.83
-0.66
-1.02
1.09
-1.14
Basic Average Shares
46,796.50
46,309.00
45,740.00
45,066.00
42,125.00
Diluted Average Shares
46,796.50
46,309.00
45,740.00
46,039.00
42,125.00
Total Operating Income as Reported
-34,158.00
-26,683.00
-42,669.00
55,205.00
-44,233.00
Total Expenses
481,731.00
425,928.00
373,048.00
321,624.00
251,121.00
Net Income from Continuing & Discontinued Operation
-38,919.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Normalized Income
-37,843.02
-30,438.00
-46,466.00
-51,891.00
-48,415.61
Interest Income
4,271.00
3,792.00
1,994.00
466.00
1,101.00
Interest Expense
6,754.00
6,925.00
4,986.00
4,918.00
4,885.00
Net Interest Income
-2,483.00
-3,133.00
-2,992.00
-4,452.00
-3,784.00
EBIT
-31,034.00
-22,922.00
-41,212.00
55,305.00
-43,156.00
EBITDA
-12,948.00
-8,109.00
-29,502.00
65,746.00
-33,608.00
Reconciled Cost of Revenue
112,853.00
98,875.00
84,439.00
68,469.00
57,222.00
Reconciled Depreciation
18,086.00
14,813.00
11,710.00
10,441.00
9,548.00
Net Income from Continuing Operation Net Minority Interest
-38,919.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Total Unusual Items Excluding Goodwill
-1,362.00
--
--
102,500.00
357.00
Total Unusual Items
-1,362.00
--
--
102,500.00
357.00
Normalized EBITDA
-11,586.00
-8,109.00
-29,502.00
-36,754.00
-33,965.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-286.02
--
--
410.00
96.39
12/31/2020 - 8/5/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AZTA Azenta, Inc.
44.93
-2.20%
 
PLSE Pulse Biosciences, Inc.
17.65
+2.98%
 
STXS Stereotaxis, Inc.
2.3400
+6.85%
 
MMSI Merit Medical Systems, Inc.
102.76
-1.90%
 
IUI1.F Intuitive Surgical, Inc.
516.00
-0.86%
 
ANGO AngioDynamics, Inc.
9.00
-1.96%
 
PDEX Pro-Dex, Inc.
49.44
-0.64%
 
FEMY Femasys Inc.
1.1900
0.00%
 
NYXH Nyxoah S.A.
8.00
+1.52%
 
SMTI Sanara MedTech Inc.
34.65
-3.37%